Erasca to Present at Upcoming Conferences in November
Erasca, Inc. (ERAS)
Company Research
Source: GlobeNewswire
SAN DIEGO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that management will participate in the following investor conferences in November 2025 and will also participate in one-on-one investor meetings at each of these conferences. Guggenheim 2nd Annual Healthcare Innovation Conference (November 10-12, 2025)Location: Boston, MA Format: Fireside Chat Date and Time: Tuesday, November 11, 2:00 pm Eastern Time Stifel 2025 Healthcare Conference (November 11-13, 2025)Location: New York, NYFormat: Fireside Chat Date and Time: Wednesday, November 12, 1:20 pm Eastern Time Jefferies Global Healthcare Conference (November 17-20, 2025) Location: London, UKFormat: Fireside ChatDate and Time: Wednesday, November 19, 10:30 am Greenwich Mean Time A live audio webcast of the events will be ava
Show less
Read more
Impact Snapshot
Event Time:
ERAS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ERAS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ERAS alerts
High impacting Erasca, Inc. news events
Weekly update
A roundup of the hottest topics
ERAS
News
- Analyst Confidence High in Erasca (ERAS) Amid Pipeline Advancement and Earlier Q3 2025 Results [Yahoo! Finance]Yahoo! Finance
- Erasca to Present at the 8th Annual Evercore Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Erasca to Present at the 8th Annual Evercore Healthcare ConferenceGlobeNewswire
- Erasca (NASDAQ:ERAS) had its price target raised by analysts at Guggenheim from $3.00 to $5.00. They now have a "buy" rating on the stock.MarketBeat
- Erasca GAAP EPS of -$0.11 in-line [Seeking Alpha]Seeking Alpha
ERAS
Earnings
- 11/12/25 - In-Line
ERAS
Sec Filings
- 11/17/25 - Form 144
- 11/14/25 - Form SCHEDULE
- 11/12/25 - Form 10-Q
- ERAS's page on the SEC website